CHARACTERIZATION OF BIOTINIDASE DEFICIENCY

生物素酶缺乏症的特征

• 批准号: 3323276
• 负责人: BARRY WOLF
• 金额: $ 17.34万
• 依托单位: VIRGINIA COMMONWEALTH UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-08-01 至 1992-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3323276
• 关键词: amidohydrolases; biotin; decarboxylases; enzyme deficiency; family genetics; fibroblasts; heterozygote; human subject; inborn metabolism disorder; inborn metabolism disorder diagnosis; infant human (0-1 year); leukocytes; mass screening; metabolism disorder chemotherapy; nutrition related tag; questionnaires; siblings; tissue /cell culture; vitamin therapy

Biotinidase is the enzyme that cleaves biotin from the final products of the proteolytic degradation of biotin-dependent carboxylases, thus recycling the vitamin. Biotinidase activity is deficient in most children with late-onset multiple carboxylase defeiciency. Affected individuals may exhibit neurologic and cutaneous features including seizures, hypotonia, ataxia, skin rash, alopecia and developmental delay, which may progress to come and ultimately death. All children with biotinidase deficiency who have been treated with biotin have improved clinically. Since the disorder met the major criteria for inclusion in newborn screening programs, we developed a simple test for determining biotinidase activity using the same blood-soaked filter paper samples used in most programs. We have been screening all the newborn infants born in Virginia since January 24, 1984 and have detected three newborns with the deficiency and two affected siblings of one of these infants. Based on our results more than a dozen states and ten foreign countries have started or will start similar newborn screening programs. Several of these programs have already detected newborns with the enzyme deficiency. We proposed to collaborate with designated physicians in states that are currently screening for biotinidase deficiency and physicians who have identified symptomatic individuals to obtain a deficiency and physicians who have identified symptomatic individuals to obtain a better understanding of the initial features and natural history of the disorder. Clinical and biochemical evaluations will be performed at regular intervals on infants and children with biotinidase deficiency detected by newborn screening or who have been identified after developing symptoms. Evaluation of their family members, particularly siblings, should provide insight into the variation of expression of the disorder and the possible existence of benign variants. Moreover, this work will provide information about the possible manifestations in heterozygotes for the disorder and the potential adverse effects of biotin treatment.

生物素酶是将生物素从终产物中分离出来的酶

项目成果

Biotinidase deficiency.

生物素酶缺乏。

• 发表时间: 1991
• 期刊: Advances in pediatrics
• 作者: Wolf,B;Heard,GS
• 通讯作者: Heard,GS

Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity.

使用准确测定残留生物素酶活性的简单方法，对临床确定的儿童严重生物素酶缺乏症和新生儿筛查进行比较。

• DOI: 10.1016/0885-4505(92)90046-2
• 发表时间: 1992
• 期刊: Biochemical medicine and metabolic biology
• 作者: Hart,PS;Barnstein,BO;SecorMcVoy,JR;Matalon,R;Wolf,B
• 通讯作者: Wolf,B

Fatty acid alterations and carboxylase deficiencies in the skin of biotin-deficient rats.

生物素缺乏大鼠皮肤中的脂肪酸改变和羧化酶缺乏。

• DOI: 10.1093/ajcn/51.5.853
• 发表时间: 1990
• 期刊: The American journal of clinical nutrition
• 作者: Proud,VK;Rizzo,WB;Patterson,JW;Heard,GS;Wolf,B
• 通讯作者: Wolf,B

Reversal of brain atrophy with biotin treatment in biotinidase deficiency.

生物素酶缺乏症中生物素治疗可逆转脑萎缩。

• DOI: 10.1055/s-2008-1071543
• 发表时间: 1993
• 期刊: Neuropediatrics
• 影响因子: 1.4
• 作者: Bousounis,DP;Camfield,PR;Wolf,B
• 通讯作者: Wolf,B

Biochemical and immunologic characterization of serum biotinidase in partial biotinidase deficiency.

部分生物素酶缺乏症血清生物素酶的生化和免疫学特征。

• DOI: 10.1203/00006450-199203000-00013
• 发表时间: 1992
• 期刊: Pediatric research
• 影响因子: 3.6
• 作者: Hart,PS;Hymes,J;Wolf,B
• 通讯作者: Wolf,B